Common skin cancer linked to other cancers
Frequent skin cancers due to mutations in genes responsible for repairing DNA are linked to a threefold risk of unrelated cancers, according to a Stanford study. The finding could help identify people for more vigilant screening.
$10 million pledge for bioscience students
The funds from the Blavatnik Family Foundation will provide permanent support for five students enrolled in the Stanford Biosciences.
Device helps kids with autism read looks
Wearing a device that identifies other people’s facial expressions can help children with autism develop better social skills, a Stanford pilot study has demonstrated.
How Biodesign technologies help patients
Stanford Biodesign trainees have developed new medical devices and diagnostics that have been used to help care for more than 1.5 million patients so far.
Toward a malaria vaccine for pregnant women
Prasanna Jagannathan said the $100,000 prize will allow his lab team to ramp up their research in Uganda.
New therapy for drug-resistant epilepsy
The FDA has approved the use of an implanted device that releases periodic electrical discharges in the brain to counteract seizures in people with epilepsy. In an interview, neurologist Robert Fisher described the technology and Stanford’s role in testing the device.
Depression, blood levels of substance linked
Investigators at Stanford and elsewhere have shown, for the first time in humans, that low blood levels of acetyl-L-carnitine track with the severity and duration of depression.
Genetic screen predicts osteoporosis risk
A new genetic screen may be able to predict low bone-mineral density, osteoporosis and fracture risk prior to clinical symptoms, according to a retrospective study of nearly 400,000 people by a Stanford researcher.
Gut molecule protects against Salmonella
A molecule called propionate inhibits the growth of Salmonella in mice and may be a promising new treatment for people sickened by the pathogen, according to a new Stanford study.
Lay worker effective in end-of-life talks
The findings suggest that patients with a serious illness are more at ease with decisions about their care when they discuss their care preferences with someone outside the medical context, according to Stanford researchers.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.